Editorial Open Access
Copyright ©2010 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Dec 21, 2010; 16(47): 5907-5907
Published online Dec 21, 2010. doi: 10.3748/wjg.v16.i47.5907
Reverse cholesterol transport revisited
Astrid E van der Velde, Academic Medical Center, AMC Liver Center, Meibergdreef 69-71, 1105 BK, Amsterdam, The Netherlands
Astrid E van der Velde, Department of Education and Development, Gelderse Vallei Hospital, 6710 HN Ede, The Netherlands
Author contributions: van der Velde AE solely contributed to this paper.
Correspondence to: Astrid E van der Velde, PhD, Department of Education and Development, Gelderse Vallei Hospital, PO Box 9025, 6710 HN Ede, The Netherlands. astridvandervelde@hotmail.com
Telephone: +31-318-891318 Fax: +31-318-436977
Received: July 2, 2010
Revised: August 25, 2010
Accepted: September 1, 2010
Published online: December 21, 2010

Abstract

Reverse cholesterol transport was originally described as the high-density lipoprotein-mediated cholesterol flux from the periphery via the hepatobiliary tract to the intestinal lumen, leading to fecal excretion. Since the introduction of reverse cholesterol transport in the 1970s, this pathway has been intensively investigated. In this topic highlight, the classical reverse cholesterol transport concepts are discussed and the subject reverse cholesterol transport is revisited.

Key Words: Cholesterol; Reverse cholesterol transport; Transintestinal cholesterol efflux; Liver; Intestine; Lipoproteins



FROM THE EDITOR

Cholesterol is of vital importance for all vertebrates. It is an essential structural component of cell membranes. In addition, cholesterol is needed for the manufacture of bile salts, steroid hormones and vitamin D. However, too much cholesterol is harmful. A high level of serum cholesterol is a risk factor for certain cardiovascular diseases. Fortunately, the body possess a transport route in order to dispose cholesterol: reverse cholesterol transport, which is an interesting target for drug development aiming at the treatment/prevention of atherosclerotic and associated diseases. Since the introduction of reverse cholesterol transport in the 1970s, this pathway has been intensively investigated.

The thorough research on reverse cholesterol transport has led to a great understanding about the way cholesterol is disposed. However, new insights in cholesterol excretion were rendered as well. Insights make the classical view on reverse cholesterol transport questionable. In this topic highlight, the classical reverse cholesterol transport concepts are discussed and the subject reverse cholesterol transport is revisited[1-7].

Footnotes

S- Editor Cheng JX L- Editor Wang XL E- Editor Zheng XM

References
1.  van der Velde AE. Reverse cholesterol transport: From classical view to new insights. World J Gastroenterol. 2010;16:5908-5915.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Hoekstra M, Van Berkel TJC, Van Eck M. Scavenger receptor BI: A multi-purpose player in cholesterol and steroid metabolism. World J Gastroenterol. 2010;16:5916-5924.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Vantourout P, Radojkovic C, Lichtenstein L, Pons V, Champagne E, Martinez LO. Ecto-F1-ATPase: A moonlighting protein complex and an unexpected apoA-I receptor. World J Gastroenterol. 2010;16:5925-5935.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  Dikkers A, Tietge UJF. Biliary cholesterol secretion: More than a simple ABC. World J Gastroenterol. 2010;16:5936-5945.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Temel RE, Brown JM. A new framework for reverse cholesterol transport: Non-biliary contributions to reverse cholesterol transport. World J Gastroenterol. 2010;16:5946-5952.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Vrins CLJ. From blood to gut: Direct secretion of cholesterol via transintestinal cholesterol efflux. World J Gastroenterol. 2010;16:5953-5957.  [PubMed]  [DOI]  [Cited in This Article: ]
7.  Pedrelli M, Pramfalk C, Parini P. Thyroid hormones and thyroid hormone receptors: Effects of thyromimetics on reverse cholesterol transport. World J Gastroenterol. 2010;16:5958-5964.  [PubMed]  [DOI]  [Cited in This Article: ]